# UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial

> **NCT04726397** · NA · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 108 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **RADIATION:** Reduced margin adaptive radiotherapy

## Key facts

- **NCT ID:** NCT04726397
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-29
- **Primary completion:** 2024-05-15
- **Final completion:** 2024-05-15
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04726397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04726397, "UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04726397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*